Quay Pharma is now part of sgs logoopens in a new window
Contact Us  
Company Overview

WORLD-LEADING INNOVATIVE FORMULATION CDMO

Company Overview

WORLD-LEADING INNOVATIVE FORMULATION CDMO

We are a Contract Development Manufacturing Organisation (CDMO). We specialise in the development of innovative new entities for biotech companies, globally.

SGS Quay PharmaWatch Introduction

World-Leading Formulation Services

We create robust formulation development strategies tailored to the characteristics of each individual API. We complement the drug discovery process with clearly set-out costs for specific stages, totally transparent from the preclinical stage, formulation, dosage form development and optimisation.

View Our Services

Live Biotherapeutics Product Delivery

Experienced formulation development and licensed for the clinical manufacture of live biotherapeutics products for digestive, urogenital and pulmonary delivery. We can prepare a strategy to bring your dosage requirement rapidly and effectively to First in Human studies, and beyond.

See How We're Leading The Way

Our Scientific Success Is Your Success

Our in-house scientific expertise enables us to approach every project from the most fundamental principles, thoroughly researching your drug and building a complete understanding of its mechanism and potential efficacy, and then providing a dosage design that will deliver the best possible results.

What Makes Us Different

Let's Talk Project Success

Talk directly to the Quay staff - Our dedicated team leaders are ready to listen and help with your project.

Contact Us  

Put Your Project In The Hands of Quay Pharma

Quay Pharma is a contract development manufacturing organisation (CDMO). Since 2002 we have proudly delivered over 250 successful projects and exercised continued improvement whilst remaining true to our core values.

Our use of proven manufacturing technologies provides a low economic risk and fast entry in to first in human trials, and its elevated scale-up to future clinical phases.

We have knowledge and expertise in the formulation and development of a wide range of product formats and dosage forms for modified and targeted release within the body.

We are licensed for the clinical and commercial manufacturing of new chemical entities, biologicals and live biotherareutics in a non-sterile environment.

Our core strength is our people, we invest in the best, only experts with strong scientific backgrounds underpins the service we deliver.

Latest News & Media From Quay Pharma

All News Articles

September 16 2022

14th Annual EuPFi Conference 2022

SGS Quay Pharma will be attending EuPFi Conference, 20th-22nd September 2022

Events

August 30 2022

Formulation & Bioavailability Summit 2022

Quay Pharma will be attending Formulation & Bioavailability Summit on 6th September 2022.

Denmark

August 08 2022

SGS Quay Pharma Receives Queen's Award for Industry

SGS Quay Pharma has received its Queen’s Award for Enterprise. The award was presented by...

Awards

Let's Talk Project Success

Talk directly to the Quay staff - Our dedicated team leaders are ready to listen and help with your project.

Contact Us